5-LOX, a catalyzing enzyme of arachidonic acid, was overexpressed during multistage tumor progression in many neoplastic disorders including lung, breast, pancreatic cancers and HCC HBx-integrated host hepatocytes [32], [33]. This evidence concerns the gene ALOX5 and familial pancreatic carcinoma.